Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Explainable Machine Learning for Predicting Dengue Recovery Duration: Insights from Multi-Center Clinical Data.

Healthcare (Basel, Switzerland)·2026
Same author

Gestational weight gain and maternal immediate perinatal and postpartum outcomes in low and middle income countries: individual participant data meta-analyses.

BMJ medicine·2026
Same author

Highly stable photothermal CO<sub>2</sub> conversion to C<sub>2</sub>H<sub>6</sub> with 87% selectivity: cooperative charge redistribution in a heteronuclear catalyst stabilizes the reaction intermediates and enhances C-C coupling.

Materials horizons·2026
Same author

Atomically dispersed cobalt on niobium oxide enables photothermal nitrogen fixation via nitrogen-hydrogen coupling.

Journal of colloid and interface science·2026
Same author

Ethosomal nanocarriers for enhanced skin drug delivery: a comprehensive review.

Molecular biology reports·2026
Same author

Letter to the Editor on "Clinical profile and optical coherence tomography based morphological characteristics of coronary in-stent restenosis: A cross-sectional study".

Indian heart journal·2026

Related Experiment Video

Updated: Nov 1, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.6K

Exploring Nanoemulsions for Prostate Cancer Therapy.

Sushmita Srivastava1, Md Faheem Haider1, Afroz Ahmad1

  • 1Faculty of Pharmacy, Integral University, Lucknow, India.

Drug Research
|June 22, 2021
PubMed
Summary

Nanoemulsions offer a novel approach for targeted prostate cancer treatment by delivering therapeutic agents directly to tumors. This innovative nanomedicine strategy holds promise for improving outcomes in managing this common malignancy.

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.2K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.2K

Related Experiment Videos

Last Updated: Nov 1, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.6K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.2K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.2K

Area of Science:

  • Oncology
  • Nanotechnology
  • Drug Delivery

Background:

  • Prostate carcinoma is a prevalent global cancer, with significant morbidity and mortality.
  • Current treatments for metastatic prostate cancer, including radiation and chemotherapy, face limitations due to disease progression.
  • Targeted delivery systems are needed to overcome therapeutic challenges in advanced prostate cancer.

Purpose of the Study:

  • To explore the potential of nanoemulsions as a drug delivery vehicle for prostate cancer treatment.
  • To highlight the advantages of nanoemulsions in targeting tumor vasculature.
  • To emphasize the formulation of nanomedicine using nanoemulsions for enhanced prostate cancer therapy.

Main Methods:

  • Review of nanoemulsion properties and their application in drug delivery.
  • Analysis of nanoemulsion characteristics, including nano-meter oil-droplet size (20-200 nm).
  • Exploration of nanoemulsions for re-purposing herbal and synthetic drugs for prostate cancer.

Main Results:

  • Nanoemulsions possess unique properties, such as nano-meter droplet size, enabling access to leaky tumor vasculature.
  • Nanoemulsions can be formulated with various therapeutic agents, including herbal and synthetic drugs.
  • This approach facilitates targeted delivery of therapeutics for prostate cancer.

Conclusions:

  • Nanoemulsions represent a promising nanomedicine platform for revolutionizing prostate cancer treatment.
  • Targeted delivery via nanoemulsions can potentially improve therapeutic efficacy and overcome limitations of conventional therapies.
  • Further research into nanoemulsion-based therapies is warranted for advanced prostate cancer management.